Zimmer Biomet (ZBH) Financial Analysis & Valuation | Quarter Chart
Zimmer Biomet (ZBH)
ZBHPrice: $91.24
Fair Value: 🔒
🔒score
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products;... more
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal health... more
Description
Shares
| Market Cap | $17.65B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Ivan Tornos |
| IPO Date | 2001-07-25 | CAGR | 0.09% |
| Employees | 17,000 | Website | www.zimmerbiomet.com |
| Div. Yield | 0.63% | Payout Ratio | 0.25% |
| Buy Back Yield | 0.91% | Total Yield | 1.54% |
ZBH chart loading...
Fundamentals
Technicals
| Enterprise Value | $25.79B | P/E Ratio | 10.76 |
| Forward P/E | 10.15 | PEG Ratio | 0.69 |
| P/S Ratio | 3.51 | P/B Ratio | 2 |
| P/CF Ratio | 17.76 | P/FCF Ratio | 16.06 |
| EPS | $8.48 | EPS Growth 1Y | -14.82% |
| EPS Growth 3Y | 79.91% | EPS Growth 5Y | 43.12% |
| Revenue Growth 1Y | 9.23% | Gross Margin | 0.7% |
| Operating Margin | 0.16% | Profit Margin | 0.09% |
| ROE | 0.06% | ROA | 0.03% |
| ROCE | 0.06% | Current Ratio | 2.94 |
| Quick Ratio | 1.61 | Cash Ratio | 0.25 |
| Debt/Equity | 0.51 | Interest Coverage | 4.44 |
| Altman Z Score | 2.04 | Piotroski Score | 9 |